These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 11920624

  • 1. Cyclopentenyl cytosine increases the phosphorylation and incorporation into DNA of 1-beta-D-arabinofuranosyl cytosine in a human T-lymphoblastic cell line.
    Verschuur AC, Van Gennip AH, Leen R, Voûte PA, Brinkman J, Van Kuilenburg AB.
    Int J Cancer; 2002 Apr 01; 98(4):616-23. PubMed ID: 11920624
    [Abstract] [Full Text] [Related]

  • 2. Cyclopentenyl cytosine induces apoptosis and increases cytarabine-induced apoptosis in a T-lymphoblastic leukemic cell-line.
    Verschuur AC, Brinkman J, Van Gennip AH, Leen R, Vet RJ, Evers LM, Voûte PA, Van Kuilenburg AB.
    Leuk Res; 2001 Oct 01; 25(10):891-900. PubMed ID: 11532523
    [Abstract] [Full Text] [Related]

  • 3. Cyclopentenyl cytosine primes SK-N-BE(2)c neuroblastoma cells for cytarabine toxicity.
    Bierau J, Van Gennip AH, Leen R, Helleman J, Caron HN, Van Kuilenburg AB.
    Int J Cancer; 2003 Jan 20; 103(3):387-92. PubMed ID: 12471622
    [Abstract] [Full Text] [Related]

  • 4. Long intracellular retention of 4'-thio-arabinofuranosylcytosine 5'-triphosphate as a critical factor for the anti-solid tumor activity of 4'-thio-arabinofuranosylcytosine.
    Someya H, Waud WR, Parker WB.
    Cancer Chemother Pharmacol; 2006 Jun 20; 57(6):772-80. PubMed ID: 16180016
    [Abstract] [Full Text] [Related]

  • 5. Metabolism of 4'-thio-beta-D-arabinofuranosylcytosine in CEM cells.
    Parker WB, Shaddix SC, Rose LM, Waud WR, Shewach DS, Tiwari KN, Secrist JA.
    Biochem Pharmacol; 2000 Dec 15; 60(12):1925-32. PubMed ID: 11108809
    [Abstract] [Full Text] [Related]

  • 6. Cellular pharmacology of cyclopentenyl cytosine in Molt-4 lymphoblasts.
    Ford H, Cooney DA, Ahluwalia GS, Hao Z, Rommel ME, Hicks L, Dobyns KA, Tomaszewski JE, Johns DG.
    Cancer Res; 1991 Jul 15; 51(14):3733-40. PubMed ID: 1712247
    [Abstract] [Full Text] [Related]

  • 7. Resistance to cyclopentenylcytosine in murine leukemia L1210 cells.
    Zhang H, Cooney DA, Zhang MH, Ahluwalia G, Ford H, Johns DG.
    Cancer Res; 1993 Dec 01; 53(23):5714-20. PubMed ID: 7694793
    [Abstract] [Full Text] [Related]

  • 8. Cytosine arabinoside transport and metabolism in acute leukemias and T cell lymphoblastic lymphoma.
    Wiley JS, Taupin J, Jamieson GP, Snook M, Sawyer WH, Finch LR.
    J Clin Invest; 1985 Feb 01; 75(2):632-42. PubMed ID: 3871794
    [Abstract] [Full Text] [Related]

  • 9. Reversal by cytidine of cyclopentenyl cytosine-induced toxicity in mice without compromise of antitumor activity.
    Ford H, Driscoll JS, Hao Z, Dobyns KA, Rommel ME, Stowe E, Anderson JO, Plowman J, Waud WR, Johns DG.
    Biochem Pharmacol; 1995 Jan 18; 49(2):173-80. PubMed ID: 7840794
    [Abstract] [Full Text] [Related]

  • 10. Cyclopentenyl cytosine increases the phosphorylation and incorporation into dna of arabinofu-ranosyl cytosine in a myeloid leukemic cell-line.
    Verschuur AC, van Gennip AH, Leen R, Voûte PA, van Kuilenburg AB.
    Adv Exp Med Biol; 2000 Jan 18; 486():311-7. PubMed ID: 11783507
    [No Abstract] [Full Text] [Related]

  • 11. The effect of cyclopentenyl cytosine on human SK-N-BE(2)-C neuroblastoma cells.
    Slingerland RJ, Van Gennip AH, Bodlaender JM, Voûte PA, Van Kuilenburg AB.
    Biochem Pharmacol; 1995 Jul 17; 50(2):277-9. PubMed ID: 7632174
    [Abstract] [Full Text] [Related]

  • 12. In vitro inhibition of cytidine triphosphate synthetase activity by cyclopentenyl cytosine in paediatric acute lymphocytic leukaemia.
    Verschuur AC, Van Gennip AH, Leen R, Meinsma R, Voute PA, van Kuilenburg AB.
    Br J Haematol; 2000 Jul 17; 110(1):161-9. PubMed ID: 10930994
    [Abstract] [Full Text] [Related]

  • 13. Retinoic acid reduces the cytotoxicity of cyclopentenyl cytosine in neuroblastoma cells.
    Bierau J, van Gennip AH, Leen R, Caron HN, van Kuilenburg AB.
    FEBS Lett; 2002 Sep 11; 527(1-3):229-33. PubMed ID: 12220665
    [Abstract] [Full Text] [Related]

  • 14. Determinants of sensitivity to 1-beta-D-arabinofuranosylcytosine in HCT 116 and NCI-H630 human colon carcinoma cells.
    Grem JL, Geoffroy F, Politi PM, Cuddy DP, Ross DD, Nguyen D, Steinberg SM, Allegra CJ.
    Mol Pharmacol; 1995 Aug 11; 48(2):305-15. PubMed ID: 7651364
    [Abstract] [Full Text] [Related]

  • 15. Nucleoside transport and cytosine arabinoside (araC) metabolism in human T lymphoblasts resistant to araC, thymidine and 6-methylmercaptopurine riboside.
    Young I, Young GJ, Wiley JS, van der Weyden MB.
    Eur J Cancer Clin Oncol; 1985 Sep 11; 21(9):1077-82. PubMed ID: 3877635
    [Abstract] [Full Text] [Related]

  • 16. The cytostatic- and differentiation-inducing effects of cyclopentenyl cytosine on neuroblastoma cell lines.
    Bierau J, van Gennip AH, Helleman J, van Kuilenburg AB.
    Biochem Pharmacol; 2001 Oct 15; 62(8):1099-105. PubMed ID: 11597578
    [Abstract] [Full Text] [Related]

  • 17. Antiproliferative effects of cyclopentenyl cytosine (NSC 375575) in human glioblastoma cells.
    Agbaria R, Kelley JA, Jackman J, Viola JJ, Ram Z, Oldfield E, Johns DG.
    Oncol Res; 1997 Oct 15; 9(3):111-8. PubMed ID: 9220496
    [Abstract] [Full Text] [Related]

  • 18. Differences in the intracellular pharmacokinetics of cytosine arabinoside (AraC) between circulating leukemic blasts and normal mononuclear blood cells.
    Hiddemann W, Schleyer E, Unterhalt M, Zühlsdorf M, Rolf C, Reuter C, Kewer U, Uhrmeister C, Wörmann B, Büchner T.
    Leukemia; 1992 Dec 15; 6(12):1273-80. PubMed ID: 1453772
    [Abstract] [Full Text] [Related]

  • 19. Studies on the antitumor activity and biochemical actions of cyclopentenyl cytosine against human colon carcinoma HT-29 in vitro and in vivo.
    Gharehbaghi K, Zhen W, Fritzer-Szekeres M, Szekeres T, Jayaram HN.
    Life Sci; 1999 Dec 15; 64(2):103-12. PubMed ID: 10069488
    [Abstract] [Full Text] [Related]

  • 20. Polymerization of the triphosphates of AraC, 2',2'-difluorodeoxycytidine (dFdC) and OSI-7836 (T-araC) by human DNA polymerase alpha and DNA primase.
    Richardson KA, Vega TP, Richardson FC, Moore CL, Rohloff JC, Tomkinson B, Bendele RA, Kuchta RD.
    Biochem Pharmacol; 2004 Dec 15; 68(12):2337-46. PubMed ID: 15548380
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.